The -2518 Promotor Polymorphism in the MCP-1 Gene Is Associated with Systemic Sclerosis
- 1 January 2005
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 124 (1) , 92-98
- https://doi.org/10.1111/j.0022-202x.2004.23512.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Role of Monocyte Chemoattractant Protein-1 and its Receptor,CCR-2, in the Pathogenesis of Bleomycin-Induced SclerodermaJournal of Investigative Dermatology, 2003
- MCP‐1 promoter polymorphism in Spanish patients with systemic lupus erythematosusTissue Antigens, 2001
- Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 −2518 G/G genotype in CAD patientsAtherosclerosis, 2001
- Chemokine expression by systemic sclerosis fibroblasts: Abnormal regulation of monocyte chemoattractant protein 1 expressionArthritis & Rheumatism, 2001
- Cell to Cell Interaction between Mesangial Cells and Macrophages Induces the Expression of Monocyte Chemoattractant Protein-1 through Nuclear Factor-κB ActivationBiochemical and Biophysical Research Communications, 2000
- A Novel Polymorphism in the MCP-1 Gene Regulatory Region That Influences MCP-1 ExpressionBiochemical and Biophysical Research Communications, 1999
- Monocyte Chemoattractant Protein-1Published by S. Karger AG ,1999
- Novel roles for chemokines and fibroblasts in interstitial fibrosisKidney International, 1998
- Costimulation of Fibroblast Collagen and Transforming Growth Factor β1 Gene Expression by Monocyte Chemoattractant Protein-1 via Specific ReceptorsJournal of Biological Chemistry, 1996
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980